Another explanation could be that AML cells that activate STAT3/5 are more proliferative, whereas AML cells that do not activate STAT3/5 are more quiescent and thereby resistant to drugs that kill dividing cells. The gene discussed is STAT3; the disease is acute myeloid leukemia.